Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study

Journal of Psychiatric Research

Volumn 41, Issue 8, 2007, Pages 625-634

  Ohrmann, Patricia ^a   Siegmund, Ansgar ^a   Suslow, Thomas ^a   Pedersen, Anya ^a   Spitzberg, Katharina ^a   Kersting, Anette ^a   Rothermundt, Matthias ^a   Arolt, Volker ^a   Heindel, Walter ^a   Pfleiderer, Bettina ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

1H MRS; Cognition; N acetylaspartate; Prefrontal cortex; Schizophrenia

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; BIOLOGICAL MARKER; CHOLINE; CLOZAPINE; GLUTAMIC ACID; GLUTAMINE; HALOPERIDOL; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; AUDITORY VERBAL LEARNING TEST; BRAIN FUNCTION; BRAIN METABOLISM; CHRONIC DISEASE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; IN VIVO STUDY; MALE; METABOLITE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME; VERBAL MEMORY;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; ASPARTIC ACID; CHOLINE; CHRONIC DISEASE; COGNITION DISORDERS; CREATINE; DOMINANCE, CEREBRAL; ENERGY METABOLISM; FEMALE; FRONTAL LOBE; GLUTAMIC ACID; GLUTAMINE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MENTAL RECALL; MIDDLE AGED; NEURONS; PHOSPHOCREATINE; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; SCHIZOPHRENIA; VERBAL LEARNING;

EID: 34047185227     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.07.002     Document Type: Article

References (89)

1. Addington J., Brooks B.L., and Addington D. Cognitive functioning in first-episode psychosis: initial presentation. Schizophrenia Research 44 (2003) 47-56
2. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. Journal of Neuroscience 16 1 (1996) 19-30
3. Albus M., Hubmann W., Ehrenberg C.h., Forcht U., Mohr F., Sobizack N., et al. Neuropsychological impairment in first-episode and chronic schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience 246 (1996) 249-255
4. Barch D.M., Sheline Y.I., Czernansky J.G., and Snyder A.Z. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biological Psychiatry 53 5 (2003) 376-384
5. Barker P.B. N-acetyl aspartate - a neuronal marker?. Annals of Neurology 49 4 (2001) 423-424
6. Barré W.F.C., Hulshoff-Pol H.E., Hijman R., Mali W.P.T., Viergever M.A., and Kahn R.S. Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biological Psychiatry 45 (1999) 1597-1605
7. Bartha R., Williamson P.C., Drost D.J., Malla M., Carr T., Cortese L., et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Archives of General Psychiatry 54 (1997) 959-965
8. Benes F.M., McSparren J., Bird E.D., San Giovanni J.P., and Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Archives of General Psychiatry 48 (1991) 996-1001
9. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Teschedi G., Frank J.A., et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry 43 (1998) 641-648
10. Bertolino A., Esposito G., Callicott J.H., Mattay V.S., van Horn J.D., Frank J.A., et al. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. American Journal of Psychiatry 157 (2000) 26-33
11. Bertolino A., Callicott J.H., Mattay V.S., Weidenhammer K.M., Rakow R., Egan M.F., et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biological Psychiatry 49 (2001) 39-46
12. Bertolino A., Sciota D., Brudaglio F., Altamura M., Blasi G., Bellomo A., et al. Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. American Journal of Psychiatry 160 (2003) 483-489
13. Bilder R.M., Goldman R.S., Robinson D., Reiter G., Bell L., Bates J.A., et al. Neuropsychology in first-episode schizophrenia: initial characterization and clinical correlates. American Journal of Psychiatry 157 (2000) 549-559
14. Bustillo J.R., Lauriello J., Rowland L.M., Thomson L.M., Petropoulos H., Hammond R., et al. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophrenia Research 58 (2002) 313-321
15. Bustillo J., Wolff C., Myers-y-Gutierrez A., Dettmer T.S., Cooper T.B., Allan A Lauriello J., et al. Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels. Schizophrenia Research 66 (2004) 31-39
16. Cahn W., Pol H.E., Lerns E., van Haren N.E., Schnack H.G., van der Linden J.A., et al. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Archives of General Psychiatry 59 (2002) 2000-2009
17. Callicott J.H., Bertolino A., Mattay V.S., Langheim F.J.P., Duyn J.H., Coppola R., et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cerebral Cortex 10 (2000) 1078-1092
18. Carter C.S., Perlstein W., Ganguli R., Brar J., Mintun M., and Cohen J.D. Functional hypofrontality and working memory dysfunction in schizophrenia. American Journal of Psychiatry 155 (1998) 1285-1287
19. Cecil K.M., Lenkinski R.E., Gur R.E., and Gur R.C. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology 20 (1999) 131-140
20. Choe B.Y., Suh T.S., Shinn K.S., Lee C.W., and Paik L.H. Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Investigative Radiology 31 (1996) 345-352
21. Crottaz-Herbette S., Anagnoson R.T., and Menon V. Modality effects in verbal working memory: differential prefrontal and parietal responses to auditory and visual stimuli. Neuroimage 21 1 (2004) 340-351
22. DeLisi L.E., Sakuma M., Tew W., Kushner M., Hoff A.L., and Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Research 74 3 (1997) 129-140
23. Demougeot C., Marie C., Giroud M., and Beley A. N-acetylaspartate: a literature review of animal research on brain ischaemia. Journal of Neurochemistry 90 4 (2004) 776-783
24. Ende G., Braus D.F., Walter S., Weber-Fahr W., Soher B., Maudsley A.A., et al. Effects of age, medication, and illness duration in the N-acetylaspartate signal of the anterior cingulate region in schizophrenia. Schizophrenia Research 41 (2000) 389-395
25. Fannon D., Simmons A., Tennakoon L., O'Ceallaigh S., Sumich A., Doku V., et al. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biological Psychiatry 54 (2003) 587-598
26. Fletcher P.C., Frith C.D., Grasby P.M., Shallice T., Frackowiak R.S., and Dolan R.J. Brain systems for encoding and retrieval of auditory-verbal memory. An in vivo study in humans. Brain 118 Pt 2 (1995) 401-416
27. Geffen G., Hoar K.J., O'Hanlon A.P., Clark C.R., and Geffen L.B. Performance measures of 16- to 86-year-old males and females on the Auditory Verbal Learning Test. Clinical Neuropsychologist 4 (1990) 45-63
28. Goldberg T.E., and Green M.F. Neurocognitive functioning in patients with schizophrenia: an overview. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: the fifth generation of progress (2002), Lippincott, Williams and Wilkins, Philadelphia 570-657
29. Grasby P.M., Frith C.D., Friston K.J., Simpson J., Fletcher P.C., Frackowiak R.S., et al. A graded task approach to the functional mapping of brain areas implicated in auditory-verbal memory. Brain 177 (1994) 1271-1282
30. Habib R., Nyberg L., and Tulving E. Hemispheric asymmetries of memory: the HERA model revisited. Trends in Cognitive Sciences 7 6 (2003) 241-245
31. Haefner H., Loeffler W., Maurer K., Riecher-Roessler A., and Stein A. IRAOS - Interview for the retrospective assessment of the onset and course of schizophrenia and other psychoses (1999), Huber, Bern
32. Haier R.J., Jung R.E., Yeo R.A., Head K., and Alkire M.T. The neuroanatomy of general intelligence: sex matters. Neuroimage 25 1 (2005) 320-327
33. Harte M.K., Bachus S.B., and Reynolds G.P. Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol. Schizophrenia Research 75 2-3 (2005) 303-308
34. Heaton R.K., Gladsjo J.A., Palmer B.W., Kuck J., Marcotte T.D., and Jeste D.V. Stability and course of neuropsychological deficits in schizophrenia. Archives of General Psychiatry 58 (2001) 24-32
35. Heimberg C., Komoroski R.A., Lawson W.B., Cardwell D., and Karson C.N. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Research: Neuroimaging 83 (1998) 105-115
36. Heinrichs R.W., and Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12 (1998) 426-445
37. Heubrock D. The auditory-verbal learning test (AVLT) in clinical and experimental neuropsychology: administration, evaluation, and research findings. Zeitschrift fuer Differentielle und Diagnostische Psychologie 13 3 (1992) 161-174
38. Hill S.K., Schuepbach D., Herberner E.S., Keshavan M.S., and Sweeney J.A. Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naive patients with schizophrenia. Schizophrenia Research 68 (2004) 49-63
39. Hoff A.L., and Kremen W.S. Neuropsychology in schizophrenia: an update. Current Opinion in Psychiatry 16 (2003) 149-155
40. Hoff A.L., Sakuma M., Wieneke M., Horon R., Kushner M., and DeLisi L.E. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. American Journal of Psychiatry 156 (1999) 1336-1341
41. Horn W. Leistungspruefsystem LPS. 2nd ed. (1983), Hogrefe, Göttingen, Germany
42. Ille N., Kapitza S., and Vogelgesang S. Rechnergestützte neuropsychologische tests (1992), Institut fuer Medizinische Informatik, Heidelberg
43. 1H-MRS study of normal human brain. Neuroimage 26 3 (2005) 965-972
44. Kay S.R., Fiszbein A., and Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13 (1987) 261-276
45. Keshavan M.S., Stanley J.A., and Pettegrew J.W. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings - Part II. Biological Psychiatry 48 5 (2000) 369-380
46. Kubicki M, McCarley R, Westin CF, Park HJ, Maier S, Kikinis R, et al., A review of diffusion tensor imaging studies in schizophrenia. Journal of Psychiatric Research, in press.
47. Lamberti G., and Weidlich S. DCS - a visual learning and memory test for neuropsychological assessment. 3rd ed. (1999), Hogrefe, Göttingen
48. Lindquist D.M., Hawk R.M., Karson C.N., and Komoroski R.A. Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo. Magnetic Resonance in Medicine 43 3 (2000) 355-358
49. Manoach D.S. Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophrenia Research 60 (2003) 285-298
50. Manoach D.S., Press D.Z., Thangaraj V., Searl M.M., Goff D.C., Halpern E., et al. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task as measured by fMRI. Biological Psychiatry 45 (1999) 1128-1137
51. McCarley R.W., Niznikiewics M.A., Salisbury D.F., Nestor P.G., O'Donnell B.F., Hirayasu Y., et al. Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects. European Archives of Psychiatry and Clinical Neuroscience 249 (1999) 69-82
52. Michael N., Erfurth A., Ohrmann P., Arolt V., Heindel W., and Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychological Medicine 33 7 (2003) 1277-1284
53. 1H-MRS) study of healthy brain. European Journal of Neuroscience 17 11 (2003) 2462-2468
54. Michaelis T., Merboldt K.D., Bruhn H., Haenicke W., and Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187 1 (1993) 219-227
55. Moffett J.R., and Namboodiri M.A. Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. Journal of Neurocytology 24 (1995) 409-433
56. Mohamed S., Paulsen J.S., O'Leary D., Arndt S., and Andreasen N. Generalized cognitive deficits in schizophrenia. Archives of General Psychiatry 56 (1999) 749-754
57. Molina V., Sanchez J., Reig S., Sanz J., Benito C., Santamarta C., et al. N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration. Schizophrenia Research 73 (2005) 209-219
58. Ohrmann P., Kersting A., Suslow T., Lalee-Mentzel J., Donges U., Fiebich M., et al. Proton magnetic resonance spectroscopy in anorexia nervosa: correlations with cognition. Neuroreport 15 3 (2004) 549-553
59. Oldfield R.C. The assessment of analysis of handedness: The Edinburgh Inventory. Neuropsychologia 9 (1971) 97-113
60. Opitz B., Mecklinger A., and Friederici A.D. Functional asymmetry of human prefrontal cortex: encoding and retrieval of verbally and nonverbally coded information. Learning & Memory 7 2 (2000) 85-96
61. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361 (2003) 281-288
62. Pantelis C., Yucel M., Wood S.J., Velakoulis D., Sun D., Berger G., et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia Bulletin 31 3 (2005) 672-696
63. Pfleiderer B., Michael N., Erfurth A., Ohrmann P., Hohmann U., Wolgast M., et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Research 122 3 (2003) 185-192
64. Pfleiderer B., Ohrmann P., Suslow T., Wolgast M., Gerlach A.L., Heindel W., et al. N-acetylaspartate levels of left frontal cortex are associated with verbal intelligence in women but not in men: a proton magnetic resonance spectroscopy study. Neuroscience 123 4 (2004) 1053-1058
65. Provencher S.W. Estimate of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 30 6 (1993) 672-679
66. Rajkowska G., and Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II Variability in locations of area 9 and 46 and relationship to Talaraich coordinate system. Cerebral Cortex 45 (1995) 323-337
67. Reneman L., Majoie C.B.L.M., Schmand B., van den Brink W., and den Heeten G.J. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biological Psychiatry 50 (2001) 550-554
68. Riehemann S., Volz H.P., Stutzer P., Smesny S., Gaser C., and Sauer H. Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test - a fMRI study. European Archives of Psychiatry and Clinical Neuroscience 251 2 (2001) 66-71
69. Ross A.J., and Sachdev P.S. Magnetic resonance spectroscopy in cognitive research. Brain Research Brain Research Reviews 44 2-3 (2004) 83-102
70. Rund B.R. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophrenia Bulletin 24 3 (1998) 425-435
71. Sandrini M., Cappa S.F., Rossi S., Rossini P.M., and Miniussi C. The role of prefrontal cortex in verbal episodic memory: rTMS evidence. Journal of Cognitive Neuroscience 15 6 (2003) 855-861
72. Saykin A.J., Shtasel D.L., Gur R.E., Kester D.B., Mozley L.H., Stafiniak P., et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Archives of General Psychiatry 51 (1994) 124-131
73. Selemon L.D., Rajkowska G., and Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of three-dimensional, stereologic counting method. Journal of Comparative Neurology 392 (1998) 402-412
74. Stanley J.A., Williamson P.C., Drost D.J., Rylett R.J., Carr T.J., Malla A., et al. An in vivo proton magnetic resonance spectroscopy study of schizophrenic patients. Schizophrenia Bulletin 22 (1996) 597-609
75. 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta analysis. Neuropsychopharmacology 30 (2005) 1949-1962
76. Stevens A.A., Goldman-Rakic P.S., Gore J.C., Fulbright R.K., and Wexler B.E. Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging. Archives of General Psychiatry 55 (1998) 1097-1103
77. Suslow T., and Arolt V. Paranoid schizophrenia: non-specificity of neuropsychological vulnerability markers. Psychiatry Research 72 (1997) 103-114
78. Tewes U. HAWIE-R: Hamburg-Wechsler Intelligenztest für Erwachsene (1991), Huber, Bern
79. Théberge J., Bartha R., Drost D.J., Menon R.S., Malla A., Takhar J., et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. American Journal of Psychiatry 159 (2002) 1944-1946
80. Théberge J., Al-Semaan Y., Williamson P.C., Menon R.S., Neufeld R.W., Rajakumar N., et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. American Journal of Psychiatry 160 (2003) 2231-2233
81. Torrey E.F. Studies of individuals with schizophrenia never treated with antipsychotic medication: a review. Schizophrenia Research 58 (2002) 101-115
82. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. Journal of Neuroscience 13 (1993) 981-989
83. Victoroff J., Mack W.J., Grafton S.T., Schreiber S.S., and Chui H.C. A method to improve interrater reliability of visual inspection of brain MRI scans in dementia. Neurology 44 (1994) 2267-2276
84. Wagner A.D., Poldrack R.A., Eldridge L.L., Desmond J.E., Glover G.H., and Gabrieli J.D. Material-specific lateralization of prefrontal activation during episodic encoding and retrieval. Neuroreport 9 16 (1998) 3711-3717
85. Weickert T.W., Goldberg T.E., Gold J.M., Bigelow L.B., Egan M.F., and Weinberger D.R. Cognitive impairments in patients with schizophrenia displaying preserved and comprised intellect. Archives of General Psychiatry 57 (2000) 907-913
86. 1H-MRS. Schizophrenia Research 49 suppl 1 (2001) 196
87. Wittchen H.U., Wunderlich U., Gruschwitz S., and Zaudig M. Strukturiertes klinisches interview für DSM-IV, Achse I (SKID) [Structured clinical interview for DSM-IV] (1997), Goettingen, Hogrefe
88. Wood S.J., Berger G., Velakoulis D., Pillips L.J., McGorry P.D., Yung A.R., et al. Proton magnetic resonance spectroscopy in first-episode psychosis and ultra-high-risk individuals. Schizophrenia Bulletin 29 (2003) 831-843
89. Zimmermann P., and Fimm B. A test battery for attentional performance. In: Leclercq M., and Zimmermann P. (Eds). Applied neuropsychology of attention. Theory, diagnosis and rehabilitation (2002), Huber, Bern 110-151